You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 43 No. 2, February 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Immunosuppressive Drug Therapy in Myasthenia Gravis

Enayat Niakan, MD; Yadollah Harati, MD; Loren A. Rolak, MD

Arch Neurol. 1986;43(2):155-156.


Abstract

• We reviewed the records of 37 patients with myasthenia gravis treated with azathioprine (n = 10) or cyclophosphamide (n = 27). All patients had received prednisone and anticholinesterase therapy, and most had undergone thymectomy prior to immunosuppressive therapy. Thirty patients (81%) responded to treatment. Both azathioprine and cyclophosphamide were found to be effective in the treatment of myasthenia gravis. The degree of improvement was more pronounced in patients with thymoma.



Author Affiliations

From the Departments of Neurology, Baylor College of Medicine and the Veterans Administration Hospital, Houston.


Footnotes

Accepted for publication July 22, 1985.

Reprint requests to Department of Neurology, Baylor College of Medicine, 6501 Fannin, Houston, TX 77030 (Dr Harati).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of autoimmune myasthenia gravis
Richman and Agius
Neurology 2003;61:1652-1661.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.